Telomir Pharmaceuticals, Inc.
TELO
$1.52
$0.021.23%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -5.07M | -2.18M | -2.90M | -5.93M | -1.45M |
| Total Depreciation and Amortization | -- | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | 0.00 | 0.00 | 0.00 |
| Total Other Non-Cash Items | 4.66M | 1.38M | 2.19M | 4.81M | -- |
| Change in Net Operating Assets | -291.00K | -59.00K | 100.50K | 123.10K | -73.80K |
| Cash from Operations | -696.40K | -863.10K | -605.80K | -1.00M | -1.52M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -132.40K | 132.40K |
| Total Debt Repaid | -- | -- | 0.00 | -433.90K | 0.00 |
| Issuance of Common Stock | 1.05M | -- | 1.04M | 0.00 | 0.00 |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | 519.50K | 0.00 |
| Cash from Financing | 1.05M | -- | 1.04M | -46.90K | 132.40K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 351.30K | -863.10K | 431.50K | -1.05M | -1.39M |